RecruitingEarly Phase 1NCT05946785
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Role of Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Sponsor
Anna Stanhewicz, PhD
Enrollment
28 participants
Start Date
Jul 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this investigation is to examine the role of oxidative stress in aberrant microvascular function in otherwise healthy women with a history of GDM.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years
Inclusion Criteria5
- female sex
- -50 years old
- pregnancy history within 5 years of the study visit
- had gestational diabetes diagnosed by their obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes
- or without a history of gestational diabetes
Exclusion Criteria9
- skin diseases
- current tobacco/e-cigarette use
- diagnosed or suspected hepatic or metabolic disease including diabetes
- statin or other cholesterol-lowering medication
- current antihypertensive medication
- history of preeclampsia or gestational hypertension
- current pregnancy
- body mass index <18.5 kg/m2
- allergy to materials used during the experiment.(e.g. latex), known allergies to study drugs.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAcetylcholine
acetylcholine is perfused at 10 ascending concentrations (10\^-10M - 10\^-1 M) for 5 minutes each
DRUGinsulin aspart
insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05946785
Related Trials
Growth Hormone Resistance of Beta-cells A
NCT065714871 location
Community Health Worker-Led Postpartum Diabetes Screening
NCT062094111 location
Continuous Glucose Monitoring for Women With Gestational Diabetes
NCT0631035614 locations
Cardiometabolic Disease and Substrate Metabolism
NCT075657271 location
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
NCT054827891 location